Search research articles
Contact Us
Filters
Showing results (61-70 of 71) with videos related to
Page
of 8
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 17, 2020
ESTRO ACROP guidelines for target volume definition in the thoracic radiation treatment of small cell lung cancer
Cecile Le Pechoux, Corinne Faivre-Finn, Sara Ramella, et al.
Medical Physics
|
January 26, 2017
Classification and evaluation strategies of auto-segmentation approaches for PET: Report of AAPM task group No. 211
Mathieu Hatt, John A Lee, Charles R Schmidtlein, et al.
Nature Communications
|
June 14, 2022
Automated detection and segmentation of non-small cell lung cancer computed tomography images
Sergey P Primakov, Abdalla Ibrahim, Janita E van Timmeren, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 13, 2020
Role of radiotherapy in the management of brain metastases of NSCLC - Decision criteria in clinical routine
Markus Glatzer, Corinne Faivre-Finn, Dirk De Ruysscher, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 2, 2024
Acute toxicity in patients with oligometastatic cancer following metastasis-directed stereotactic body radiotherapy: An interim analysis of the E<sup>2</sup>-RADIatE OligoCare cohort
Filippo Alongi, Luca Nicosia, Umberto Ricardi, et al.
Clinical Lung Cancer
|
September 20, 2021
Role of Postoperative Radiotherapy in the Management for Resected NSCLC - Decision Criteria in Clinical Routine Pre- and Post-LungART
Krisztian Süveg, Cecile Le Pechoux, Corinne Faivre-Finn, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 20, 2024
Cancer-specific dose and fractionation schedules in stereotactic body radiotherapy for oligometastatic disease: An interim analysis of the EORTC-ESTRO E<sup>2</sup>-RADIatE OligoCare study
Sebastian M Christ, Filippo Alongi, Umberto Ricardi, et al.
BMC Cancer
|
June 17, 2020
Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: a multicentre, randomised controlled open-label phase II trial
Relinde I Y Lieverse, Evert J Van Limbergen, Cary J G Oberije, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 24, 2024
Stereotactic Body Radiotherapy for Centrally Located Inoperable Early-Stage NSCLC: EORTC 22113-08113 LungTech Phase II Trial Results
Antonin Levy, Sonja Adebahr, Coen Hurkmans, et al.
The Lancet. Oncology
|
March 1, 2023
Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC-ESTRO OligoCare consortium
Stephanie G C Kroeze, Matea Pavic, Karin Stellamans, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 71) with videos related to
Sort By:
Page
of 8
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 17, 2020
ESTRO ACROP guidelines for target volume definition in the thoracic radiation treatment of small cell lung cancer
Cecile Le Pechoux, Corinne Faivre-Finn, Sara Ramella, et al.
Medical Physics
|
January 26, 2017
Classification and evaluation strategies of auto-segmentation approaches for PET: Report of AAPM task group No. 211
Mathieu Hatt, John A Lee, Charles R Schmidtlein, et al.
Nature Communications
|
June 14, 2022
Automated detection and segmentation of non-small cell lung cancer computed tomography images
Sergey P Primakov, Abdalla Ibrahim, Janita E van Timmeren, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 13, 2020
Role of radiotherapy in the management of brain metastases of NSCLC - Decision criteria in clinical routine
Markus Glatzer, Corinne Faivre-Finn, Dirk De Ruysscher, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 2, 2024
Acute toxicity in patients with oligometastatic cancer following metastasis-directed stereotactic body radiotherapy: An interim analysis of the E<sup>2</sup>-RADIatE OligoCare cohort
Filippo Alongi, Luca Nicosia, Umberto Ricardi, et al.
Clinical Lung Cancer
|
September 20, 2021
Role of Postoperative Radiotherapy in the Management for Resected NSCLC - Decision Criteria in Clinical Routine Pre- and Post-LungART
Krisztian Süveg, Cecile Le Pechoux, Corinne Faivre-Finn, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 20, 2024
Cancer-specific dose and fractionation schedules in stereotactic body radiotherapy for oligometastatic disease: An interim analysis of the EORTC-ESTRO E<sup>2</sup>-RADIatE OligoCare study
Sebastian M Christ, Filippo Alongi, Umberto Ricardi, et al.
BMC Cancer
|
June 17, 2020
Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: a multicentre, randomised controlled open-label phase II trial
Relinde I Y Lieverse, Evert J Van Limbergen, Cary J G Oberije, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 24, 2024
Stereotactic Body Radiotherapy for Centrally Located Inoperable Early-Stage NSCLC: EORTC 22113-08113 LungTech Phase II Trial Results
Antonin Levy, Sonja Adebahr, Coen Hurkmans, et al.
The Lancet. Oncology
|
March 1, 2023
Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC-ESTRO OligoCare consortium
Stephanie G C Kroeze, Matea Pavic, Karin Stellamans, et al.
Page
of 8